Brouns Sanne L N, Tullemans Bibian M E, Bulato Cristiana, Perrella Gina, Campello Elena, Spiezia Luca, van Geffen Johanna P, Kuijpers Marijke J E, van Oerle René, Spronk Henri M H, van der Meijden Paola E J, Simioni Paolo, Heemskerk Johan W M
Departments of Biochemistry and Internal Medicine CARIM Maastricht University Medical Centre Maastricht The Netherlands.
Department of Medicine University of Padua Medical School Padova Italy.
Res Pract Thromb Haemost. 2022 Mar 7;6(2):e12678. doi: 10.1002/rth2.12678. eCollection 2022 Feb.
BACKGROUND: Low plasma levels of protein C or protein S are associated with venous thromboembolism rather than myocardial infarction. The high coagulant activity in patients with thrombophilia with a (familial) defect in protein C or S is explained by defective protein C activation, involving thrombomodulin and protein S. This causes increased plasmatic thrombin generation. OBJECTIVE: Assess the role of platelets in the thrombus- and fibrin-forming potential in patients with familial protein C or protein S deficiency under high-shear flow conditions. PATIENTS/METHODS: Whole blood from 23 patients and 15 control subjects was perfused over six glycoprotein VI-dependent microspot surfaces. By real-time multicolor microscopic imaging, kinetics of platelet thrombus and fibrin formation were characterized in 49 parameters. RESULTS AND CONCLUSION: Whole-blood flow perfusion over collagen, collagen-like peptide, and fibrin surfaces with low or high GPVI dependency indicated an unexpected impairment of platelet activation, thrombus phenotype, and fibrin formation but unchanged platelet adhesion, observed in patients with protein C deficiency and to a lesser extent protein S deficiency, when compared to controls. The defect extended from diminished phosphatidylserine exposure and thrombus contraction to delayed and suppressed fibrin formation. The mechanism was thrombomodulin independent, and may involve negative platelet priming by plasma components.
背景:血浆中蛋白C或蛋白S水平较低与静脉血栓栓塞有关,而非心肌梗死。蛋白C或S存在(家族性)缺陷的血栓形成倾向患者的高凝血活性是由涉及血栓调节蛋白和蛋白S的蛋白C活化缺陷所解释的。这会导致血浆凝血酶生成增加。 目的:评估在高剪切流条件下,血小板在家族性蛋白C或蛋白S缺乏患者血栓和纤维蛋白形成潜能中的作用。 患者/方法:将23例患者和15例对照者的全血灌注到六个糖蛋白VI依赖性微斑点表面。通过实时多色显微镜成像,以49个参数表征血小板血栓和纤维蛋白形成的动力学。 结果与结论:与对照组相比,在蛋白C缺乏患者以及程度较轻的蛋白S缺乏患者中,全血在低或高糖蛋白VI依赖性的胶原蛋白、类胶原蛋白肽和纤维蛋白表面的流动灌注显示血小板活化、血栓表型和纤维蛋白形成出现意外损伤,但血小板黏附未改变。该缺陷从磷脂酰丝氨酸暴露减少和血栓收缩延伸至纤维蛋白形成延迟和受抑制。其机制与血栓调节蛋白无关,可能涉及血浆成分对血小板的负性预刺激。
Res Pract Thromb Haemost. 2022-3-7
Arterioscler Thromb Vasc Biol. 2016-4
J Thromb Haemost. 2017-10-27
Arterioscler Thromb Vasc Biol. 2012-4-19
Res Pract Thromb Haemost. 2018-5-20
Arterioscler Thromb Vasc Biol. 2021-2
Cureus. 2024-6-23
Int J Mol Sci. 2023-6-25
Front Cardiovasc Med. 2021-1-8
Arterioscler Thromb Vasc Biol. 2021-2
Haematologica. 2018-12-13